e-learning
resources
Monograph
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
End-points and biomarkers for clinical trials in cystic fibrosis
Kris De Boeck, Isabelle Fajac, Felix Ratjen
Source:
Eur Respir Monogr 2014; 64: 104-115
Journal Issue:
Cystic Fibrosis
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kris De Boeck, Isabelle Fajac, Felix Ratjen. End-points and biomarkers for clinical trials in cystic fibrosis. Eur Respir Monogr 2014; 64: 104-115
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
The concept of cystic fibrosis pulmonary exacerbation in clinical medicine and as a trial end-point
Source: Annual Congress 2008 - Exacerbations of chronic respiratory disease – state of the art
Year: 2008
Alternative multiple breath washout outcomes for clinical trials in cystic fibrosis
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new therapies and detection of early lung disease
Year: 2012
Exacerbations in non cystic fibrosis bronchiectasis: clinical features and investigations
Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood
Year: 2009
Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice
Source: International Congress 2015 – Treatment of IPF
Year: 2015
Doxycycline improves clinical outcomes during cystic fibrosis exacerbations
Source: Eur Respir J , 49 (4) 1601102; DOI: 10.1183/13993003.01102-2016
Year: 2017
Clinical trials in interstitial lung disease
Source: Eur Respir Mon; 2009: 46: 67–84
Year: 2009
Do patients with cystic fibrosis participating in clinical trials demonstrate placebo response ? A meta-analysis.
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019
Aspergillus pulmonary disease in cystic fibrosis (CF) patients: multicentre perspective observational study based on new diagnostic tests to evaluate the prognostic value on the CF disease
Source: Virtual Congress 2021 – Adult cystic fibrosis
Year: 2021
Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis- A randomised controlled trial
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2017
Prospective evaluation of cardio-metabolic comorbidities in a cohort of patients with non-cystic fibrosis bronchiectasis.
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020
Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J, 53 (3) 1800663; 10.1183/13993003.00663-2018
Year: 2019
Prognostic value of clinical exercise testing in adult patients with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008
Prospective study on clinical and immunological Aspergillus categorization in cystic fibrosis.
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences
Source: Eur Respir Rev 2015; 24: 420-427
Year: 2015
Heterogeneity of treatment response in bronchiectasis clinical trials
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials
Source: Eur Respir J 2015; 46: 243-249
Year: 2015
Inflammatuary markers in induced sputum and clinical parameters in children with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2004 - Chronic respiratory illness in childhood
Year: 2004
Enzymatic activity and clinical parameters in non-cystic fibrosis bronchiectasis: A cohort analysis
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
Long-term outcomes and clinical worsening in cystic fibrosis patients with at least one residual function mutation
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept